Gut microbiota and inflammation analyses reveal the protective effect of medium-chain triglycerides combined with docosahexaenoic acid on cognitive function in APP/PS1 and SAMP8 mice

•Medium-chain triglycerides (MCTs) combined with DHA improve cognitive function.•16S rRNA shows that MCTs combined with DHA optimize gut microbiota composition.•Proteobacteria and Firmicutes/Bacteroidota (F/B) ratio are linked with inflammation.•MCTs combined with DHA down-regulate the abundance of...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Nutrition research (New York, N.Y.) N.Y.), 2024-12, Vol.132, p.27-39
Hauptverfasser: Wang, Zehao, Sun, Yue, Zhang, Dalong, Wang, Yue, Zhou, Dezheng, Li, Wen, Yan, Jing, Chen, Yongjie, Luo, Suhui, Qian, Zhiyong, Li, Zhenshu, Huang, Guowei
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 39
container_issue
container_start_page 27
container_title Nutrition research (New York, N.Y.)
container_volume 132
creator Wang, Zehao
Sun, Yue
Zhang, Dalong
Wang, Yue
Zhou, Dezheng
Li, Wen
Yan, Jing
Chen, Yongjie
Luo, Suhui
Qian, Zhiyong
Li, Zhenshu
Huang, Guowei
description •Medium-chain triglycerides (MCTs) combined with DHA improve cognitive function.•16S rRNA shows that MCTs combined with DHA optimize gut microbiota composition.•Proteobacteria and Firmicutes/Bacteroidota (F/B) ratio are linked with inflammation.•MCTs combined with DHA down-regulate the abundance of Proteobacteria and F/B ratio. Accumulating evidence has demonstrated that medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA) positively affect cognitive function. However, it remains unclear whether the improvement is related to the alterations of gut microbiota and inflammation and the impact of the combined intervention. In this study, we hypothesized that the supplementation of MCTs combined with DHA could modulate gut microbiota, inflammation, and improve cognitive function in APPswe/PS1De9 model mice and senescence-accelerated mouse-prone-8, which are two different mouse models used in neurodegeneration research. The mice were divided into four groups: Control group, MCTs group, DHA group, and MCTs + DHA group. The study assessed cognitive function, inflammatory cytokines, and gut microbiota composition. The results showed that supplementation of MCTs + DHA improved spatial learning ability, memory capacity, exploratory behavior; decreased the relative abundance of Proteobacteria; reduced the ratio of Firmicutes/Bacteroidetes; decreased the concentrations of serum interleukin (IL)-2, IL-6, monocyte chemotactic protein-1, tumor necrosis factor-alpha, while increasing the concentration of IL-10. Furthermore, supplementation with MCTs + DHA exhibited significantly superior effects compared to MCTs or DHA alone in reducing inflammation, optimizing gut microbiota composition, and improving cognitive function. In conclusion, supplementation with MCTs + DHA improved cognition function, accompanied with favorable alterations in gut microbiota and inflammation in APPswe/PS1De9 and senescence-accelerated mouse-prone-8 mice. MCTs and DHA positively modulate the gut microbiota, reduce inflammation, and improve cognitive function. When the supplementation of MCTs combined with DHA intervened, the relative abundance of Proteobacteria, the ratio of F/B, the levels of inflammation were reduced, and cognitive function was improved in APP/PS1 and SAMP8 mice. The mechanisms may be related to gut microbiota and inflammation. DHA, docosahexaenoic acid; F/B, Firmicutes/Bacteroidota; MCTs, medium-chain triglycerides. [Display omitted]
doi_str_mv 10.1016/j.nutres.2024.09.015
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_3119722125</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S0271531724001295</els_id><sourcerecordid>3119722125</sourcerecordid><originalsourceid>FETCH-LOGICAL-c287t-e9eb9ed5c0ce908a0b9600e2756fe69b4cddd516916840bdb90d1d4e6088e49f3</originalsourceid><addsrcrecordid>eNp9UctuEzEUtRCIhsIfIOQlm5nanqc3SFFVClIRkQpry2PfaW40YxfbE8iP8X04SWHJylfWedx7DiFvOSs54-3VrnRLChBLwURdMlky3jwjK953smBdJZ-TFRMdL5qKdxfkVYw7xnjHq-oluahkXXWNaFfk9-2S6Iwm-AF90lQ7S9GNk55nndC7_KGnQ4RIA-xBTzRtgT4Gn8Ak3AOFccwT9SOdweIyF2ar0dEU8GE6GAhoM9X4eUAHlv7EtKXWGx_1Fn5pcB4N1QYtzU7GPzg8iY6LMyfzrLTebK429_y02P36y6Y_bguvyYtRTxHePL2X5PvHm2_Xn4q7r7efr9d3hRF9lwqQMEiwjWEGJOs1G2TLGIiuaUdo5VAba23DW8nbvmaDHSSz3NbQsr6HWo7VJXl_1s0n_1ggJjVjNDBN2oFfoqo4l50QXDQZWp-hOcsYA4zqMeCsw0Fxpo6NqZ06N6aOjSkmVW4s0949OSxDjvAf6W9FGfDhDIB85x4hqGgQnMlxhxy9sh7_7_AHRiethg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>3119722125</pqid></control><display><type>article</type><title>Gut microbiota and inflammation analyses reveal the protective effect of medium-chain triglycerides combined with docosahexaenoic acid on cognitive function in APP/PS1 and SAMP8 mice</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><creator>Wang, Zehao ; Sun, Yue ; Zhang, Dalong ; Wang, Yue ; Zhou, Dezheng ; Li, Wen ; Yan, Jing ; Chen, Yongjie ; Luo, Suhui ; Qian, Zhiyong ; Li, Zhenshu ; Huang, Guowei</creator><creatorcontrib>Wang, Zehao ; Sun, Yue ; Zhang, Dalong ; Wang, Yue ; Zhou, Dezheng ; Li, Wen ; Yan, Jing ; Chen, Yongjie ; Luo, Suhui ; Qian, Zhiyong ; Li, Zhenshu ; Huang, Guowei</creatorcontrib><description>•Medium-chain triglycerides (MCTs) combined with DHA improve cognitive function.•16S rRNA shows that MCTs combined with DHA optimize gut microbiota composition.•Proteobacteria and Firmicutes/Bacteroidota (F/B) ratio are linked with inflammation.•MCTs combined with DHA down-regulate the abundance of Proteobacteria and F/B ratio. Accumulating evidence has demonstrated that medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA) positively affect cognitive function. However, it remains unclear whether the improvement is related to the alterations of gut microbiota and inflammation and the impact of the combined intervention. In this study, we hypothesized that the supplementation of MCTs combined with DHA could modulate gut microbiota, inflammation, and improve cognitive function in APPswe/PS1De9 model mice and senescence-accelerated mouse-prone-8, which are two different mouse models used in neurodegeneration research. The mice were divided into four groups: Control group, MCTs group, DHA group, and MCTs + DHA group. The study assessed cognitive function, inflammatory cytokines, and gut microbiota composition. The results showed that supplementation of MCTs + DHA improved spatial learning ability, memory capacity, exploratory behavior; decreased the relative abundance of Proteobacteria; reduced the ratio of Firmicutes/Bacteroidetes; decreased the concentrations of serum interleukin (IL)-2, IL-6, monocyte chemotactic protein-1, tumor necrosis factor-alpha, while increasing the concentration of IL-10. Furthermore, supplementation with MCTs + DHA exhibited significantly superior effects compared to MCTs or DHA alone in reducing inflammation, optimizing gut microbiota composition, and improving cognitive function. In conclusion, supplementation with MCTs + DHA improved cognition function, accompanied with favorable alterations in gut microbiota and inflammation in APPswe/PS1De9 and senescence-accelerated mouse-prone-8 mice. MCTs and DHA positively modulate the gut microbiota, reduce inflammation, and improve cognitive function. When the supplementation of MCTs combined with DHA intervened, the relative abundance of Proteobacteria, the ratio of F/B, the levels of inflammation were reduced, and cognitive function was improved in APP/PS1 and SAMP8 mice. The mechanisms may be related to gut microbiota and inflammation. DHA, docosahexaenoic acid; F/B, Firmicutes/Bacteroidota; MCTs, medium-chain triglycerides. [Display omitted]</description><identifier>ISSN: 0271-5317</identifier><identifier>ISSN: 1879-0739</identifier><identifier>EISSN: 1879-0739</identifier><identifier>DOI: 10.1016/j.nutres.2024.09.015</identifier><identifier>PMID: 39437526</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Alzheimer Disease ; Animals ; APP/PS1 mouse ; Cognition - drug effects ; Cognitive function ; Cytokines - blood ; Cytokines - metabolism ; Dietary Supplements ; Disease Models, Animal ; Docosahexaenoic acid ; Docosahexaenoic Acids - administration &amp; dosage ; Docosahexaenoic Acids - pharmacology ; Gastrointestinal Microbiome - drug effects ; Gut microbiota ; Inflammation - prevention &amp; control ; Inflammatory cytokines ; Male ; Medium-chain triglycerides ; Mice ; Mice, Transgenic ; SAMP8 mouse ; Triglycerides - blood</subject><ispartof>Nutrition research (New York, N.Y.), 2024-12, Vol.132, p.27-39</ispartof><rights>2024 The Author(s)</rights><rights>Copyright © 2024 The Author(s). Published by Elsevier Inc. All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c287t-e9eb9ed5c0ce908a0b9600e2756fe69b4cddd516916840bdb90d1d4e6088e49f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.sciencedirect.com/science/article/pii/S0271531724001295$$EHTML$$P50$$Gelsevier$$Hfree_for_read</linktohtml><link.rule.ids>314,776,780,3536,27903,27904,65309</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/39437526$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Wang, Zehao</creatorcontrib><creatorcontrib>Sun, Yue</creatorcontrib><creatorcontrib>Zhang, Dalong</creatorcontrib><creatorcontrib>Wang, Yue</creatorcontrib><creatorcontrib>Zhou, Dezheng</creatorcontrib><creatorcontrib>Li, Wen</creatorcontrib><creatorcontrib>Yan, Jing</creatorcontrib><creatorcontrib>Chen, Yongjie</creatorcontrib><creatorcontrib>Luo, Suhui</creatorcontrib><creatorcontrib>Qian, Zhiyong</creatorcontrib><creatorcontrib>Li, Zhenshu</creatorcontrib><creatorcontrib>Huang, Guowei</creatorcontrib><title>Gut microbiota and inflammation analyses reveal the protective effect of medium-chain triglycerides combined with docosahexaenoic acid on cognitive function in APP/PS1 and SAMP8 mice</title><title>Nutrition research (New York, N.Y.)</title><addtitle>Nutr Res</addtitle><description>•Medium-chain triglycerides (MCTs) combined with DHA improve cognitive function.•16S rRNA shows that MCTs combined with DHA optimize gut microbiota composition.•Proteobacteria and Firmicutes/Bacteroidota (F/B) ratio are linked with inflammation.•MCTs combined with DHA down-regulate the abundance of Proteobacteria and F/B ratio. Accumulating evidence has demonstrated that medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA) positively affect cognitive function. However, it remains unclear whether the improvement is related to the alterations of gut microbiota and inflammation and the impact of the combined intervention. In this study, we hypothesized that the supplementation of MCTs combined with DHA could modulate gut microbiota, inflammation, and improve cognitive function in APPswe/PS1De9 model mice and senescence-accelerated mouse-prone-8, which are two different mouse models used in neurodegeneration research. The mice were divided into four groups: Control group, MCTs group, DHA group, and MCTs + DHA group. The study assessed cognitive function, inflammatory cytokines, and gut microbiota composition. The results showed that supplementation of MCTs + DHA improved spatial learning ability, memory capacity, exploratory behavior; decreased the relative abundance of Proteobacteria; reduced the ratio of Firmicutes/Bacteroidetes; decreased the concentrations of serum interleukin (IL)-2, IL-6, monocyte chemotactic protein-1, tumor necrosis factor-alpha, while increasing the concentration of IL-10. Furthermore, supplementation with MCTs + DHA exhibited significantly superior effects compared to MCTs or DHA alone in reducing inflammation, optimizing gut microbiota composition, and improving cognitive function. In conclusion, supplementation with MCTs + DHA improved cognition function, accompanied with favorable alterations in gut microbiota and inflammation in APPswe/PS1De9 and senescence-accelerated mouse-prone-8 mice. MCTs and DHA positively modulate the gut microbiota, reduce inflammation, and improve cognitive function. When the supplementation of MCTs combined with DHA intervened, the relative abundance of Proteobacteria, the ratio of F/B, the levels of inflammation were reduced, and cognitive function was improved in APP/PS1 and SAMP8 mice. The mechanisms may be related to gut microbiota and inflammation. DHA, docosahexaenoic acid; F/B, Firmicutes/Bacteroidota; MCTs, medium-chain triglycerides. [Display omitted]</description><subject>Alzheimer Disease</subject><subject>Animals</subject><subject>APP/PS1 mouse</subject><subject>Cognition - drug effects</subject><subject>Cognitive function</subject><subject>Cytokines - blood</subject><subject>Cytokines - metabolism</subject><subject>Dietary Supplements</subject><subject>Disease Models, Animal</subject><subject>Docosahexaenoic acid</subject><subject>Docosahexaenoic Acids - administration &amp; dosage</subject><subject>Docosahexaenoic Acids - pharmacology</subject><subject>Gastrointestinal Microbiome - drug effects</subject><subject>Gut microbiota</subject><subject>Inflammation - prevention &amp; control</subject><subject>Inflammatory cytokines</subject><subject>Male</subject><subject>Medium-chain triglycerides</subject><subject>Mice</subject><subject>Mice, Transgenic</subject><subject>SAMP8 mouse</subject><subject>Triglycerides - blood</subject><issn>0271-5317</issn><issn>1879-0739</issn><issn>1879-0739</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2024</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UctuEzEUtRCIhsIfIOQlm5nanqc3SFFVClIRkQpry2PfaW40YxfbE8iP8X04SWHJylfWedx7DiFvOSs54-3VrnRLChBLwURdMlky3jwjK953smBdJZ-TFRMdL5qKdxfkVYw7xnjHq-oluahkXXWNaFfk9-2S6Iwm-AF90lQ7S9GNk55nndC7_KGnQ4RIA-xBTzRtgT4Gn8Ak3AOFccwT9SOdweIyF2ar0dEU8GE6GAhoM9X4eUAHlv7EtKXWGx_1Fn5pcB4N1QYtzU7GPzg8iY6LMyfzrLTebK429_y02P36y6Y_bguvyYtRTxHePL2X5PvHm2_Xn4q7r7efr9d3hRF9lwqQMEiwjWEGJOs1G2TLGIiuaUdo5VAba23DW8nbvmaDHSSz3NbQsr6HWo7VJXl_1s0n_1ggJjVjNDBN2oFfoqo4l50QXDQZWp-hOcsYA4zqMeCsw0Fxpo6NqZ06N6aOjSkmVW4s0949OSxDjvAf6W9FGfDhDIB85x4hqGgQnMlxhxy9sh7_7_AHRiethg</recordid><startdate>202412</startdate><enddate>202412</enddate><creator>Wang, Zehao</creator><creator>Sun, Yue</creator><creator>Zhang, Dalong</creator><creator>Wang, Yue</creator><creator>Zhou, Dezheng</creator><creator>Li, Wen</creator><creator>Yan, Jing</creator><creator>Chen, Yongjie</creator><creator>Luo, Suhui</creator><creator>Qian, Zhiyong</creator><creator>Li, Zhenshu</creator><creator>Huang, Guowei</creator><general>Elsevier Inc</general><scope>6I.</scope><scope>AAFTH</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>202412</creationdate><title>Gut microbiota and inflammation analyses reveal the protective effect of medium-chain triglycerides combined with docosahexaenoic acid on cognitive function in APP/PS1 and SAMP8 mice</title><author>Wang, Zehao ; Sun, Yue ; Zhang, Dalong ; Wang, Yue ; Zhou, Dezheng ; Li, Wen ; Yan, Jing ; Chen, Yongjie ; Luo, Suhui ; Qian, Zhiyong ; Li, Zhenshu ; Huang, Guowei</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c287t-e9eb9ed5c0ce908a0b9600e2756fe69b4cddd516916840bdb90d1d4e6088e49f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2024</creationdate><topic>Alzheimer Disease</topic><topic>Animals</topic><topic>APP/PS1 mouse</topic><topic>Cognition - drug effects</topic><topic>Cognitive function</topic><topic>Cytokines - blood</topic><topic>Cytokines - metabolism</topic><topic>Dietary Supplements</topic><topic>Disease Models, Animal</topic><topic>Docosahexaenoic acid</topic><topic>Docosahexaenoic Acids - administration &amp; dosage</topic><topic>Docosahexaenoic Acids - pharmacology</topic><topic>Gastrointestinal Microbiome - drug effects</topic><topic>Gut microbiota</topic><topic>Inflammation - prevention &amp; control</topic><topic>Inflammatory cytokines</topic><topic>Male</topic><topic>Medium-chain triglycerides</topic><topic>Mice</topic><topic>Mice, Transgenic</topic><topic>SAMP8 mouse</topic><topic>Triglycerides - blood</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Wang, Zehao</creatorcontrib><creatorcontrib>Sun, Yue</creatorcontrib><creatorcontrib>Zhang, Dalong</creatorcontrib><creatorcontrib>Wang, Yue</creatorcontrib><creatorcontrib>Zhou, Dezheng</creatorcontrib><creatorcontrib>Li, Wen</creatorcontrib><creatorcontrib>Yan, Jing</creatorcontrib><creatorcontrib>Chen, Yongjie</creatorcontrib><creatorcontrib>Luo, Suhui</creatorcontrib><creatorcontrib>Qian, Zhiyong</creatorcontrib><creatorcontrib>Li, Zhenshu</creatorcontrib><creatorcontrib>Huang, Guowei</creatorcontrib><collection>ScienceDirect Open Access Titles</collection><collection>Elsevier:ScienceDirect:Open Access</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Nutrition research (New York, N.Y.)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Wang, Zehao</au><au>Sun, Yue</au><au>Zhang, Dalong</au><au>Wang, Yue</au><au>Zhou, Dezheng</au><au>Li, Wen</au><au>Yan, Jing</au><au>Chen, Yongjie</au><au>Luo, Suhui</au><au>Qian, Zhiyong</au><au>Li, Zhenshu</au><au>Huang, Guowei</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Gut microbiota and inflammation analyses reveal the protective effect of medium-chain triglycerides combined with docosahexaenoic acid on cognitive function in APP/PS1 and SAMP8 mice</atitle><jtitle>Nutrition research (New York, N.Y.)</jtitle><addtitle>Nutr Res</addtitle><date>2024-12</date><risdate>2024</risdate><volume>132</volume><spage>27</spage><epage>39</epage><pages>27-39</pages><issn>0271-5317</issn><issn>1879-0739</issn><eissn>1879-0739</eissn><abstract>•Medium-chain triglycerides (MCTs) combined with DHA improve cognitive function.•16S rRNA shows that MCTs combined with DHA optimize gut microbiota composition.•Proteobacteria and Firmicutes/Bacteroidota (F/B) ratio are linked with inflammation.•MCTs combined with DHA down-regulate the abundance of Proteobacteria and F/B ratio. Accumulating evidence has demonstrated that medium-chain triglycerides (MCTs) and docosahexaenoic acid (DHA) positively affect cognitive function. However, it remains unclear whether the improvement is related to the alterations of gut microbiota and inflammation and the impact of the combined intervention. In this study, we hypothesized that the supplementation of MCTs combined with DHA could modulate gut microbiota, inflammation, and improve cognitive function in APPswe/PS1De9 model mice and senescence-accelerated mouse-prone-8, which are two different mouse models used in neurodegeneration research. The mice were divided into four groups: Control group, MCTs group, DHA group, and MCTs + DHA group. The study assessed cognitive function, inflammatory cytokines, and gut microbiota composition. The results showed that supplementation of MCTs + DHA improved spatial learning ability, memory capacity, exploratory behavior; decreased the relative abundance of Proteobacteria; reduced the ratio of Firmicutes/Bacteroidetes; decreased the concentrations of serum interleukin (IL)-2, IL-6, monocyte chemotactic protein-1, tumor necrosis factor-alpha, while increasing the concentration of IL-10. Furthermore, supplementation with MCTs + DHA exhibited significantly superior effects compared to MCTs or DHA alone in reducing inflammation, optimizing gut microbiota composition, and improving cognitive function. In conclusion, supplementation with MCTs + DHA improved cognition function, accompanied with favorable alterations in gut microbiota and inflammation in APPswe/PS1De9 and senescence-accelerated mouse-prone-8 mice. MCTs and DHA positively modulate the gut microbiota, reduce inflammation, and improve cognitive function. When the supplementation of MCTs combined with DHA intervened, the relative abundance of Proteobacteria, the ratio of F/B, the levels of inflammation were reduced, and cognitive function was improved in APP/PS1 and SAMP8 mice. The mechanisms may be related to gut microbiota and inflammation. DHA, docosahexaenoic acid; F/B, Firmicutes/Bacteroidota; MCTs, medium-chain triglycerides. [Display omitted]</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>39437526</pmid><doi>10.1016/j.nutres.2024.09.015</doi><tpages>13</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0271-5317
ispartof Nutrition research (New York, N.Y.), 2024-12, Vol.132, p.27-39
issn 0271-5317
1879-0739
1879-0739
language eng
recordid cdi_proquest_miscellaneous_3119722125
source MEDLINE; Elsevier ScienceDirect Journals
subjects Alzheimer Disease
Animals
APP/PS1 mouse
Cognition - drug effects
Cognitive function
Cytokines - blood
Cytokines - metabolism
Dietary Supplements
Disease Models, Animal
Docosahexaenoic acid
Docosahexaenoic Acids - administration & dosage
Docosahexaenoic Acids - pharmacology
Gastrointestinal Microbiome - drug effects
Gut microbiota
Inflammation - prevention & control
Inflammatory cytokines
Male
Medium-chain triglycerides
Mice
Mice, Transgenic
SAMP8 mouse
Triglycerides - blood
title Gut microbiota and inflammation analyses reveal the protective effect of medium-chain triglycerides combined with docosahexaenoic acid on cognitive function in APP/PS1 and SAMP8 mice
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-24T14%3A18%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Gut%20microbiota%20and%20inflammation%20analyses%20reveal%20the%20protective%20effect%20of%20medium-chain%20triglycerides%20combined%20with%20docosahexaenoic%20acid%20on%20cognitive%20function%20in%20APP/PS1%20and%20SAMP8%20mice&rft.jtitle=Nutrition%20research%20(New%20York,%20N.Y.)&rft.au=Wang,%20Zehao&rft.date=2024-12&rft.volume=132&rft.spage=27&rft.epage=39&rft.pages=27-39&rft.issn=0271-5317&rft.eissn=1879-0739&rft_id=info:doi/10.1016/j.nutres.2024.09.015&rft_dat=%3Cproquest_cross%3E3119722125%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=3119722125&rft_id=info:pmid/39437526&rft_els_id=S0271531724001295&rfr_iscdi=true